Advertisement
Research Article

Use of a Bacteriophage Lysin to Identify a Novel Target for Antimicrobial Development

  • Raymond Schuch mail,

    rschuch@contrafect.com

    Affiliation: Laboratory of Bacterial Pathogenesis and Immunology, The Rockefeller University, New York, New York, United States of America

    Current address: ContraFect Corporation, Yonkers, New York, United States of America

    X
  • Adam J. Pelzek,

    Affiliation: Laboratory of Bacterial Pathogenesis and Immunology, The Rockefeller University, New York, New York, United States of America

    X
  • Assaf Raz,

    Affiliation: Laboratory of Bacterial Pathogenesis and Immunology, The Rockefeller University, New York, New York, United States of America

    X
  • Chad W. Euler,

    Affiliation: Laboratory of Bacterial Pathogenesis and Immunology, The Rockefeller University, New York, New York, United States of America

    X
  • Patricia A. Ryan,

    Affiliations: Laboratory of Bacterial Pathogenesis and Immunology, The Rockefeller University, New York, New York, United States of America, Hunter College School of Health Sciences, New York, New York, United States of America

    X
  • Benjamin Y. Winer,

    Affiliation: Laboratory of Bacterial Pathogenesis and Immunology, The Rockefeller University, New York, New York, United States of America

    X
  • Andrew Farnsworth,

    Affiliation: Information Science Program, Cornell Lab of Ornithology, Ithaca, New York, United States of America

    X
  • Shyam S. Bhaskaran,

    Affiliation: Laboratory of Structural Microbiology, The Rockefeller University, New York, New York, United States of America

    X
  • C. Erec Stebbins,

    Affiliation: Laboratory of Structural Microbiology, The Rockefeller University, New York, New York, United States of America

    X
  • Yong Xu,

    Affiliation: Astex Pharmaceuticals, Inc. (formerly known as SuperGen, Inc.), Dublin, California, United States of America

    X
  • Adrienne Clifford,

    Affiliation: Astex Pharmaceuticals, Inc. (formerly known as SuperGen, Inc.), Dublin, California, United States of America

    X
  • David J. Bearss,

    Affiliation: Astex Pharmaceuticals, Inc. (formerly known as SuperGen, Inc.), Dublin, California, United States of America

    Current address: Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, United States of America

    X
  • Hariprasad Vankayalapati,

    Affiliation: Astex Pharmaceuticals, Inc. (formerly known as SuperGen, Inc.), Dublin, California, United States of America

    Current address: Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, United States of America

    X
  • Allan R. Goldberg,

    Affiliation: Astex Pharmaceuticals, Inc. (formerly known as SuperGen, Inc.), Dublin, California, United States of America

    Current address: Avacyn Pharmaceuticals, Inc., Teaneck, New Jersey, United States of America

    X
  • Vincent A. Fischetti

    Affiliation: Laboratory of Bacterial Pathogenesis and Immunology, The Rockefeller University, New York, New York, United States of America

    X
  • Published: April 10, 2013
  • DOI: 10.1371/journal.pone.0060754

Reader Comments (1)

Post a new comment on this article